Gastroenterology

Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study



Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study

Source link

Related posts

Disparities by ZIP Code; Most Favor E-Cig Control; Undiagnosed Cancer in Kids

Newsemia

Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic HBV

Newsemia

Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World